神经活性甾体对神经元的作用

神经活性甾体是指神经组织中具有活性的甾体激素,根据甾体激素的作用机制可分为三类：（1）通过细胞表面离子通道型受体介导产生效应,这些受体包括GABAA受体,NMDA受体等。（2）通过G蛋白偶联的膜受体指导第二信使反应,再通过DNA结合蛋白,调节基因表达产生效应,（3）通过细胞内受体介导调控基因的表达产生效应,甾体激素的这些效应尤其是对离子通道型受体和G蛋白偶联型受体的调节作用,已引起重视。     

结核分枝杆菌感染对人巨噬细胞离子通道及其调控元件转录表达的影响

为研究人巨噬细胞的离子通道及其调控元件是否参与了抗结核分枝杆菌感染免疫,利用表达谱芯片技术研究细菌感染后主巨噬细胞基因的表达情况,在全局表达谱分析的基础上,重点分析了离子通道及其调控元件的表达,并比较无毒株和临床分离有毒株在诱导离子通道及其调控元件表达方面的差异。结果表明,细菌感染影响离子通道及其调控元件基因的表达,涉及的离子通道包括钾通道、钠通道、氯通道、钙通道,差异表达的调控元件包括G蛋白、G蛋白偶联受体、蛋白质激酶和磷酸化酶;临床株感染影响的离子通道及其调控元件较无毒株广泛和丰富。这些观察结果提示,离子通道及其调控元件参与了宿主细胞对感染细菌的免疫应答,有关离子通道及其调控元件在抗结核免疫中的作用有待进一步研究。芯片研究的结果为将来的研究提供了线索。     

质子感知受体与肿瘤发生和肿瘤转移之间的关系

G蛋白偶联受体家族卵巢癌G蛋白偶联受体1（ovarian cancer G protein-coupled receptor 1, OGR1）亚家族的OGR1、T细胞死亡偶联基因8（T－cell death associated gene 8, TDAG8）、G 蛋白偶联受体4（G protein－coupled receptor 4, GPR4）及诱导细胞停滞于G2/M期的G蛋白偶联受体G2A（from G2 accumulation）4 种受体是最新发现的一类质子感知受体.除了质子,体内又有它们各自特定的脂质分 子配体活化这些受体来调节细胞机能.该类受体广泛分布于人的各种正常组织和肿瘤 组织细胞中,在肿瘤的发生与转移、细胞骨架重组等生理病理过程中发挥双重作用. 正常表达时它们有一定的抑制肿瘤作用,但这些受体的异常表达或过表达使某些组织 和细胞恶性转化,导致肿瘤的发生.本文综述了在肿瘤组织的酸性微环境中,细胞表 达的质子（pH）感知受体对肿瘤发生与肿瘤转移的调节作用及其相关的信号通路.     

中枢神经系统中与G蛋白偶联的内向整流钾通道

G蛋白偶联的内向整流钾通道（GIRK）在中枢神经系统中具有广泛分布,并且与多种受体相偶联,在神经突触后抑制中具有重要作用。本文简要介绍了近年来G蛋白偶联钾通道在基因结构、脑内组织分布、细胞内调控,以及脑功能方面的研究结果。关于GIRK在中枢神经系统中的生理和病理意义还有待进一步研究。     

脂肪因子Apelin对2型糖尿病的调控作用

Apelin是G蛋白偶联受体APJ的特异性配体,在多种组织中均有表达。对Apelin作为一种有益的脂肪因子,可通过不同的信号通路调控糖代谢和脂代谢,并对胰岛素的分泌具有一定的调控作用,在2型糖尿病的发生和发展中起着重要的调控作用,现就Apelin对2型糖尿病的调控作用作一综述。     

小细胞肺癌中转录因子E2F1调控的靶基因（英文）北大核心CSCD

本研究组前期研究结果表明,转录因子E2F1在大约95%的小细胞肺癌组织中表达上调,而且与其浸润、转移密切相关,但是E2F1在小细胞肺癌中调控的靶基因未见报道。本研究旨在探索E2F1在小细胞肺癌细胞株H1688中调控的靶基因。染色体免疫共沉淀联合测序(chromatin immunoprecipitation sequencing,Ch IP-seq)结果显示,在小细胞肺癌H1688细胞中,E2F1能够调控5 326个靶基因的表达,其中4 700个是结构基因,626个基因编码长链非编码RNA。基因功能注释(gene ontology,GO)和基因富集图谱(enrichment map)分析显示,E2F1调控的靶基因功能主要集中在3个方面:细胞周期调控、染色体和组蛋白修饰以及蛋白转运。MEME4.7.0软件分析显示,E2F1通过结合6个序列调控相关靶基因和长链非编码序列的表达。以上结果阐明了E2F1在小细胞肺癌中调控的靶基因,为进一步研究E2F1在小细胞肺癌发生、发展、浸润与转移、复发和耐药中的作用提供了实验依据。     

小细胞肺癌中转录因子E2F1调控的靶基因（英文）

本研究组前期研究结果表明,转录因子E2F1在大约95%的小细胞肺癌组织中表达上调,而且与其浸润、转移密切相关,但是E2F1在小细胞肺癌中调控的靶基因未见报道。本研究旨在探索E2F1在小细胞肺癌细胞株H1688中调控的靶基因。染色体免疫共沉淀联合测序(chromatin immunoprecipitation sequencing,Ch IP-seq)结果显示,在小细胞肺癌H1688细胞中,E2F1能够调控5 326个靶基因的表达,其中4 700个是结构基因,626个基因编码长链非编码RNA。基因功能注释(gene ontology,GO)和基因富集图谱(enrichment map)分析显示,E2F1调控的靶基因功能主要集中在3个方面:细胞周期调控、染色体和组蛋白修饰以及蛋白转运。MEME4.7.0软件分析显示,E2F1通过结合6个序列调控相关靶基因和长链非编码序列的表达。以上结果阐明了E2F1在小细胞肺癌中调控的靶基因,为进一步研究E2F1在小细胞肺癌发生、发展、浸润与转移、复发和耐药中的作用提供了实验依据。     

钾离子通道蛋白Shaker对果蝇心脏衰老的保护作用

钾离子通道在心肌细胞动作电位复极过程中起着重要作用。钾离子通道蛋白种类繁多,已知钾离子通道蛋白KCNQ和HERG/eag参与心脏动作电位的形成,调节心脏收缩节律。钾离子通道蛋白Shaker是果蝇(Drosophila)体内发现的第一个电压门控钾离子通道,维持神经元和肌肉细胞的电兴奋性,但是目前其在成人心脏功能中的作用仍不清楚。本研究以果蝇为模型,高频电刺激模拟心脏应激状态,观察钾离子通道蛋白shaker基因突变体的心衰发生率。同时,利用心脏特异性启动子hand4.2Gal4特异性敲低钾离子通道蛋白Shaker的表达;果蝇成体心脏生理学功能分析系统分析了1、3、5周龄特异性敲低钾离子通道蛋白Shaker的心脏表型。结果表明,shaker基因突变将严重影响果蝇心脏抗应激能力,表现在高频电刺激后的心力衰竭发生率显著性升高;心脏特异性敲低shaker基因导致5周龄果蝇心律失常发生率显著性增加;心脏特异性敲低HDAC3将显著降低果蝇寿命。综上所述,本研究推测钾离子通道蛋白Shaker在衰老过程中维护果蝇正常的心脏功能。     

雌激素受体

雌激素受体包括两大类:一是经典的核受体,包括ERα和ERβ,它们位于细胞核内,介导雌激素的基因型效应,即通过调节特异性靶基因的转录而发挥"基因型"调节效应;二是膜性受体,包括经典核受体的膜性成分以及属于G蛋白偶联受体家族的GPER1(GPR30)、Gαq-ER和ER-X,它们介导快速的非基因型效应,通过第二信使系统发挥间接的转录调控功能,其中一些似乎只在脑局部起作用。这两类受体在机体内的分布具有组织/细胞特异性,参与了对诸如生殖、学习、记忆、认知等多种功能的调节。     

G蛋白偶联受体激酶的调控

G蛋白偶联受体激酶(G protein-coupled receptor kinase,GRK)特异地使活化的G蛋白偶联受体(G protein-coupled receptor,GPCR)发生磷酸化及脱敏化,从而终止后者介导的信号转导通路。研究表明,GRK的功能被高度调控,并具有下行调节GPCR的能力。调控GRK功能的机制包括两个层次：(1)多种途径调控激酶的亚细胞定位及活性,包括GPCR介导、G蛋白偶联、磷脂作用、Ca^2 结合蛋白调控、蛋白激酶C活化、MAPK反馈抑制、小窝蛋白抑制等;(2)调控GRK表达水平,主要体现在其与某些疾病的联系。     

Expression of the mitochondrial creatine kinase genes

Mitochondrial Creatine Kinase (MtCK) is responsible for the transfer of high energy phosphate from mitochondria to the cytosolic carrier, creatine, and exists in mammals as two isoenzymes encoded by separate genes. In rats and humans, sarcomere-specific MtCK (sMtCK) is expressed only in skeletal and heart muscle, and has 87% nucleotide identity across the 1257 bp coding region. The ubiquitous isoenzyme of MtCK (uMtCK) is expressed in many tissues with highest levels in brain, gut, and kidney, and has 92% nucleotide identity between the 1254 bp coding regions of rat and human. Both genes are highly regulated developmentally in a tissue-specific manner. There is virtually no expression of sMtCK mRNA prior to birth. Unlike cytosolic muscle CK (MCK) and brain CK (BCK), there is no developmental isoenzyme switch between the MtCKs. Cell culture models representing the tissue-specific expression of either sMtCK or uMtCK are available, but there are no adequate developmental models to examine their regulation. Several animal models are available to examine the coordinate regulation of the CK gene family and include 1) Cardiac Stress by coarctation (sMtCK, BCK, and MCK), 2) Uterus and placenta during pregnancy (uMtCK and BCK), and 3) Diabetes and mitochondrial myopathy (sMtCK, BCK, and MCK). We report the details of these findings, and discuss the coordinate regulation of the genes necessary for high-energy transduction.     

Biophysical,pharmacological, and functional characteristics of cloned and native mammalian two-pore domain K<Superscript>+</Superscript> channels

The mammalian family of two-pore domain K⁺ (K2P) channel proteins are encoded by 15 KCNK genes and subdivided into six subfamilies on the basis of sequence similarities: TWIK, TREK, TASK, TALK, THIK, and TRESK. K2P channels are expressed in cells throughout the body and have been implicated in diverse cellular functions including maintenance of the resting potential and regulation of excitability, sensory transduction, ion transport, and cell volume regulation, as well as metabolic regulation and apoptosis. In recent years K2P channel isoforms have been identified as important targets of several widely employed drugs, including: general anesthetics, local anesthetics, neuroprotectants, and anti-depressants. An important goal of future studies will be to identify the basis of drug actions and channel isoform selectivity. This goal will be facilitated by characterization of native K2P channel isoforms, their pharmacological properties and tissue-specific expression patterns. To this end the present review examines the biophysical, pharmacological, and functional characteristics of cloned mammalian K2P channels and compares this information with the limited data available for native K2P channels in order to determine criteria which may be useful in identifying ionic currents mediated by native channel isoforms and investigating their pharmacological and functional characteristics.     

Dual modulation of a potassium channel by the m1 muscarinic and beta2-adrenergic receptors

Neurotransmitter receptors alter membrane excitability and synaptic efficacy by generating intracellular signals that ultimately change the properties of ion channels. Given their critical role in controlling cell membrane potential, potassium channels are frequently the targets of modulatory signals from many different G protein-coupled receptors. However, due to the heterogeneity of potassium channel expression in vivo, it has been difficult to determine the molecular mechanisms governing the regulation of molecularly defined potassium channels. Through expression studies in Xenopus oocytes and mammalian cells, we found that the m1 muscarinic acetylcholine receptor (mAChR) potently suppresses a cloned delayed rectifier potassium channel, termed RAK, through a pathway involving phospholipase C activation and direct tyrosine phosphorylation of the RAK protein. In contrast, we found that RAK channel activity is strongly enhanced following agonist activation of beta2-adrenergic receptors; this effect requires a single PKA consensus phosphorylation site located near the amino terminus of the channel protein. These results demonstrate that a specific type of potassium channel that is widely expressed in the mammalian brain and heart is subject to both positive and negative regulation by G protein-dependent pathways.